{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T04:33:26Z","timestamp":1792643606040,"version":"4.5.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","trasci.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion and Apheresis Science"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.transci.2023.103732","type":"journal-article","created":{"date-parts":[[2023,5,22]],"date-time":"2023-05-22T11:48:53Z","timestamp":1684756133000},"page":"103732","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Efficacy of allogeneic platelet growth factors in actinic cystitis: The resolution of trouble?"],"prefix":"10.1016","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2101-0817","authenticated-orcid":false,"given":"Luciano","family":"Abbruzzese","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Nescis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Turco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pasqualina","family":"Amoroso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giancamillo","family":"Carluccio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.transci.2023.103732_bib1","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1080\/02841860410030661","article-title":"A systematic overview of radiation therapy effects in prostate cancer","volume":"43","author":"Nilsson","year":"2004","journal-title":"Acta Oncol"},{"key":"10.1016\/j.transci.2023.103732_bib2","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1080\/02841860310014426","article-title":"A systematic overview of radiation therapy effects in ovarian cancer","volume":"42","author":"Einhorn","year":"2003","journal-title":"Acta Oncol"},{"key":"10.1016\/j.transci.2023.103732_bib3","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/S0360-3016(02)03006-7","article-title":"Interim report of toxicity from 3D conformal radiation therapy (3D-CRT) for prostate cancer on 3DOG\/RTOG 9406, level III (79.2 GY)","volume":"54","author":"Ryu","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.transci.2023.103732_bib4","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.ijrobp.2004.11.028","article-title":"Toxicity after three-dimensional radiotherapy for prostate cancer with RTOG 9406 dose level IV","volume":"62","author":"Michalski","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.transci.2023.103732_bib5","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.ijrobp.2004.07.715","article-title":"Acute and late complication after radiotherapy for prostate cancer: results of a multicenter randomized trial comparing 68 Gy to 78 Gy","volume":"61","author":"Peeters","year":"2005","journal-title":"IJ Rad Onc Biol Phys"},{"key":"10.1016\/j.transci.2023.103732_bib6","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0360-3016(98)00037-6","article-title":"Estimation of the incidence of late bladder and rectum complication after high-dose (70\u201378\u2009Gy) conformal radiotherapy for prostate cancer, using dose-volume histograms","volume":"41","author":"Boersma","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.transci.2023.103732_bib7","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1006\/gyno.1994.1278","article-title":"Hemorrhagic cystitis following radiotherapy for stage 1B cancer of the cervix","volume":"55","author":"Levenback","year":"1994","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.transci.2023.103732_bib8","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0360-3016(02)02907-3","article-title":"Phase III study of ibuprofen versus placebo for radiation-induced genitourinary side effects","volume":"54","author":"Coleman","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.transci.2023.103732_bib9","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0140-6736(98)05180-0","article-title":"Comparison of radiation side-effects of conformal and conventional radiotherapy in prostate cancer: a randomized trial","volume":"353","author":"Dearnaley","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.transci.2023.103732_bib10","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/S0360-3016(99)00232-1","article-title":"Efficacy of selective alpha-1 blocker therapy in the treatment of acute urinary symptoms during radiotherapy for localized prostate cancer","volume":"45","author":"Zelefsky","year":"1999","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.transci.2023.103732_bib11","first-page":"CO015","article-title":"Use of cranberry supplement (cistiflux) in reducing bladder toxicity from radiotherapy for prostate cancer","author":"Minissale","year":"2011","journal-title":"Abstr AIRO Genova"},{"key":"10.1016\/j.transci.2023.103732_bib12","doi-asserted-by":"crossref","first-page":"E79","DOI":"10.5489\/cuaj.4047","article-title":"Intrevescical formalin for hemorrhagic cystitis: a contemporary cohort","volume":"11","author":"Ziegelmann","year":"2017","journal-title":"Can Urol Assoc J"},{"key":"10.1016\/j.transci.2023.103732_bib13","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S0140-6736(95)91620-2","article-title":"Hyperbaric oxygen therapy for the management of hemorrhagic radiation cystitis","volume":"346","author":"Bevers","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.transci.2023.103732_bib14","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0167-8140(01)00430-3","article-title":"Hyperbaric oxygen an effective tool to treat radiation morbidity in prostate cancer","volume":"61","author":"Mayer","year":"2001","journal-title":"Radiol Oncol"},{"key":"10.1016\/j.transci.2023.103732_bib15","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.urology.2004.10.050","article-title":"Hyperbaric oxygen therapy improves outcome for radiation-induced hemorrhagic cystitis","volume":"65","author":"Chong","year":"2005","journal-title":"Urology"},{"key":"10.1016\/j.transci.2023.103732_bib16","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1464-410X.2005.05577.x","article-title":"Hyperbaric oxygen therapy for radiation-induced haemorrhagic cystitis","volume":"96","author":"Neheman","year":"2005","journal-title":"BJU Int"},{"key":"10.1016\/j.transci.2023.103732_bib17","first-page":"869","article-title":"Hyperbaric oxygen therapy for the management of hemorrhagic radio induced cystitis","volume":"64","author":"Vilar","year":"2011","journal-title":"Arch Esp Urol"},{"key":"10.1016\/j.transci.2023.103732_bib18","first-page":"4","article-title":"A systematic review of the literature reporting the application of hyperbaric oxygen prevention and treatment of delayed radiation injuries evidence based approach","volume":"29","author":"Feldmeier","year":"2002","journal-title":"Undersea Hyperb Med"},{"key":"10.1016\/j.transci.2023.103732_bib19","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.urology.2016.04.015","article-title":"Evaluation of hyperbaric oxygen therapy in the treatment of radiation-induced hemorrhagic cystitis","volume":"94","author":"Mougin","year":"2016","journal-title":"Urology"},{"key":"10.1016\/j.transci.2023.103732_bib20","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.biologicals.2011.01.002","article-title":"Treatment of recalcitrant ulcers with allogeneic platelet gel from pooled platelets in aged hypomobile patients","volume":"39","author":"Greppi","year":"2011","journal-title":"Biologicals"},{"key":"10.1016\/j.transci.2023.103732_bib21","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1097\/PRS.0b013e3181cb6589","article-title":"Treatment of diabetic foot ulcers using a blood bank platelet concentrate","volume":"125","author":"Jeong","year":"2010","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.transci.2023.103732_bib22","first-page":"1","article-title":"Platelet-rich plasma support for its use in wound healing","volume":"83","author":"Lacci","year":"2010","journal-title":"Yale J Biol Med"},{"key":"10.1016\/j.transci.2023.103732_bib23","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/vox.12039","article-title":"Release modulation and analytic quantification of growth factors in platelet concentrates","volume":"105","author":"Durante","year":"2013","journal-title":"Vox Sang"},{"key":"10.1016\/j.transci.2023.103732_bib24","first-page":"1","article-title":"Advanced with platelet rich plasma therapy for tendon regeneration","volume":"7","author":"Andia","year":"2018","journal-title":"Expert Opin Biol Ther"},{"key":"10.1016\/j.transci.2023.103732_bib25","doi-asserted-by":"crossref","DOI":"10.1902\/jop.2017.130710","article-title":"Platelet-rich fibrin in regeneration of intrabony defects: A randomized controlled trial","volume":"88","author":"Patel","year":"2017","journal-title":"J Periodontol"},{"issue":"3","key":"10.1016\/j.transci.2023.103732_bib26","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/scrt218","article-title":"Platelet-rich plasma preparation for regenerative medicine: optimization and quantification of cytokines and growth factors","volume":"4","author":"Paola","year":"2013","journal-title":"Stem Cell Res Ther"}],"container-title":["Transfusion and Apheresis Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050223001064?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050223001064?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T08:55:34Z","timestamp":1761468934000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1473050223001064"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":26,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["S1473050223001064"],"URL":"https:\/\/doi.org\/10.1016\/j.transci.2023.103732","relation":{},"ISSN":["1473-0502"],"issn-type":[{"value":"1473-0502","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy of allogeneic platelet growth factors in actinic cystitis: The resolution of trouble?","name":"articletitle","label":"Article Title"},{"value":"Transfusion and Apheresis Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transci.2023.103732","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103732"}}